March 29, 2023

Volume XIII, Number 88


March 29, 2023

Subscribe to Latest Legal News and Analysis

March 28, 2023

Subscribe to Latest Legal News and Analysis

March 27, 2023

Subscribe to Latest Legal News and Analysis

Proposed NY Marijuana Regulation and Taxation Act to Legalize, Tax, and Regulate Adult-Use Cannabis

The New York Legislature is considering and is expected to pass the Marijuana Regulation and Taxation Act (MRTA). If passed, the MRTA will create a new framework to regulate the production and sale of cannabis. The legislation will create a new adult-use cannabis program and expand the existing medical cannabis and cannabinoid (CBD) hemp programs.

The Office of Cannabis Management

The MRTA will place the three programs under the control of the Office of Cannabis Management (OCM), within the Division of Alcohol Beverage Control. The OCM will be led by an executive director, assisted by a chief equity officer and governed by a five-member Cannabis Control Board (the Board).

There will also be a 13-member Advisory Board to include experts in several fields including health, social equity, cannabis, and agriculture, with geographic and diverse membership.

The powers of the OCM include the establishment of cultivation and processing standards, caps, and limitations; the licensure of all business entities in the production and distribution process; the inspection and enforcement of the adult-use, medical, and CBD hemp programs; and the promulgation of all associated regulations. The OCM will determine details such as the types of products allowed in each program, advertising and marketing rules, product labeling rules, the number of licenses, the process for licensure, and the implementation of a social equity program.

Market Structure

For the adult-use cannabis program, the bill proposes a tiered market structure, similar to the structure of the state’s alcohol industry. Generally, vertical integration (i.e., engaged in multiple license categories) is prohibited for entities licensed in the adult-use cannabis program, with limited exceptions for the Registered Organizations operating in the medical cannabis program and microbusinesses.

License categories will include cultivation, processing, distribution, retail dispensaries, consumption sites and delivery. There will is also be a cooperative license category that would authorize groups of individuals to cultivate and process cannabis products, and a nursery license to allow for immature plants to be grown and sold to other licensees. A microbusiness license would allow the holder to cultivate, produce, and retail their own cannabis products, but will be limited in size.

For new applicants to the adult-use cannabis program, the OCM will assess licensing fees on the applicants. Applicants can seek licenses for both cultivation and processing, and/or for distribution, or for retail, but may not be vertically integrated. Furthermore, entities with retail licenses may not have direct or indirect ownership in more than three retail locations.

Social equity will be a noteworthy feature of the MRTA and includes a goal of 50% of licenses being issued to social equity applicants in the adult-use program. Such applicants will include those from communities impacted by cannabis prohibition; minority- and women-owned businesses; distressed farmers; or service-disabled veterans.

Local Control, Taxes and Social Equity Fund

If passed and adopted into law, the MRTA will provide cities, towns, and villages with an option to opt out from having adult-use dispensaries and/or adult-use social consumption sites located in their communities and will require the appropriate governing body to pass a local law in order to opt out. Any opt-out laws will need to be passed by Dec. 31, 2021 (or within nine months of the effective date of the legislation, whichever is later). In addition, any local law opting out of adult-use retail or consumption sites can be overturned by a local referendum process.

The MRTA will impose a requirement that adult-use distributors remit taxes based on the per milligram amount of THC (0.5 cents for cannabis flower, 0.8 cents for cannabis concentrate, 3.0 cents for edibles). In addition, a 13% tax is imposed upon retail sale (4% of the tax is allocated to localities (1% goes to the county, and 3% is divided at the local level based on retail sales). GT intends to issue a future alert on the tax issues.

All revenue raised from the sale of adult-use and medical cannabis would go into a new Cannabis Revenue Fund. Administration of the medical, adult-use, and CBD hemp programs would be paid out of the Cannabis Revenue Fund. Remaining revenue would flow into three funds:

  • 40% to the State Lottery Fund for Education

  • 20% to the Drug Treatment and Public Education Fund

  • 40% to the Community Grants Reinvestment Fund

The Community Grants Reinvestment Fund will be administered by the Advisory Board. The money in this fund will be used for grants for qualified community-based organizations and approved local government entities to reinvest in communities disproportionately affected by past federal and state drug policies.


The Legislature appears likely to pass the MRTA this week, and the governor is expected to sign the bill shortly thereafter. At that point, the process to appoint members to the Board and set up the OCM would begin in earnest. Oversight of the existing medical cannabis and hemp CBD programs would transition to the OCM with cooperation from the existing regulators. As for the adult-use roll out, there are a number of issues that will be implemented through the regulatory process, but the tax provisions are effective April 1, 2022, indicating a target date for sales to launch.

©2023 Greenberg Traurig, LLP. All rights reserved. National Law Review, Volume XI, Number 89

About this Author

Lynelle Bosworth Healthcare Lawyer Greenberg Traurig Law Firm

Lynelle Bosworth focuses her practice on government law and policy issues and advises clients on renewable energy, environmental, transportation, finance, racing and gaming, insurance and health care related matters. Lynelle represents private and publicly owned companies and not-for-profit organizations regarding state and federal regulatory and policy matters.

In addition, Lynelle provides legal counsel to health insurers, HMOs and other health care clients in regulatory compliance matters, business negotiations, and corporate transactions. She has wide-ranging experience...

Katharine Neer, Greenberg Traurig Law Firm, Albany, Government Policy Attorney

Katharine J. Neer assists clients on New York State legislative and regulatory issues. Specifically, Katie works with the financial services industry on regulatory compliance issues, including compliance with cybersecurity rules and various labor issues.

Prior to joining the firm, Katie served as Assistant Secretary for General Government and Financial Services in the New York State Governor’s Office. At the Governor’s office, Katie was a member of the state operations team overseeing policy and operations for six agencies: the Department of...